Results 201 to 210 of about 7,598 (253)

From Bone Health to Lifespan: Pleiotropic Effects of Antiresorptive Agents. [PDF]

Endocrinol Metab (Seoul)
Kim KJ.
europepmc   +1 more source

Long-term bisphosphonate use and femoral morphological changes in osteoporosis patients: a retrospective cohort study. [PDF]

Eur J Med Res
Zhu J, Shen C, McCulloch R, Ling D, Xu K, Wu L, Bao J, Lee GW, Jiang L.   +8 more
europepmc   +1 more source

Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review. [PDF]

Medicina (Kaunas)
Jakonyte A, Gustainyte E, Petronis Z, Hafizov A, Janovskiene A, Razukevicius D.   +5 more
europepmc   +1 more source

Effect of Severe Bowing in Bisphosphonate-Related Atypical Femoral Fracture. [PDF]

Clin Orthop Surg
Park JW, Lee YK, Ko YS, Byun SE, Cho YH, Koo KH.   +5 more
europepmc   +1 more source

Critical Analysis of the Effect of Antiresorptive Drugs on Osteonecrosis Associated With Dental Implants: An Umbrella Review. [PDF]

Cureus
Dahiya M, Dhawan P, Rani S, Saxena V.
europepmc   +1 more source

Integrative Epigenomic and Targeted Protein Analysis in MRONJ: Correlating DNA Methylation with Bone Biomarkers. [PDF]

Int J Mol Sci
Alshammari RA, Tantawy M, Wang D, Castro-Hall E, Abreu M, Villa A, Katz J, Holliday LS, Gong Y.   +8 more
europepmc   +1 more source

Increased Sensitivity of 99mTc-Diphosphonate Over Radiography in Skeletal Imaging for Metastases.

, 1974
Morton Me
openalex   +1 more source

Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer. [PDF]

Breast
Zecca E, Zambelli L, Tinè G, Bracchi P, Miceli R, Pigni A, Lo Dico S, Ricchini F, Mariani G, Massa G, Caraceni A.   +10 more
europepmc   +1 more source